Special Pathogens and Emerging Infectious Diseases Symposium

Thursday, October 5, 2023, 7:30 AM - Friday, October 6, 2023, 4:00 PM, Ronald Reagan Intl Trade Center, Washington, DC


Two-day symposium on topics pertinent to improving the medical care to be given to patients suspected or known to have a special pathogen illness. Topics to be discussed range from the evolution of the National Special Pathogen System "NSPS" to programmatic design and implementation related to PPE, training and education, BCU program administration and special practice considerations.

1. Outline the evolution of the National Special Pathogen System since Covid
2. Discuss the role NETEC and Regional Emerging Special Pathogen Treatment Centers play in enhancing EMS and hospital readiness for suspected special pathogen patients
3. Describe key elements that effective prehospital and hospital planning for special pathogens should address
4. Discuss the various operational challenges healthcare providers are facing when dealing with patients ill with a suspected or confirmed special pathogen patient
5. Identify the emerging role telehealth is playing in patient care and personnel safety
6. Discuss the ethical and medico/legal issues associated with the medical care of adult and pediatric special pathogen patients

This conference has reached capacity and is now closed for registrations.

 For questions regarding the conference, please contact: Craig DeAtley, PA-C, 202-257-4714 or the BCU program office, 202-877-9232

 

This conference is COMPLIMENTARY to all attendees, however, you must register to attend.

 

Grant provided by: Health & Human Services ASPR VCU Program

Attention Maryland Physician Learners: To ensure accurate CME credit data reporting to the Maryland licensing board, click on My CE ->Profile to review and update your profile with the following details: your full name, state of licensure, state license number, and your birth month and day. Additionally, please remember to check the box at the bottom of the profile screen to grant permission for us to report your completion data to ACCME and the Maryland licensing board. Questions? Email [email protected]  

In support of improving patient care, MedStar Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. 

 

Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 10.75 Interprofessional Continuing Education (IPCE) credits for learning and change.

 

 

Physicians: MedStar Health designates this enduring material for a maximum of 10.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Nurses: This activity is approved for 10.75 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants: 
MedStar Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 10.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

  

AMA PRA Category 1 Credits™ Physician (10.75 hours), Non-Physician Member of the Healthcare Team (10.75 hours), Nurse - ANCC (10.75 hours), Physician Assistant - AAPA (10.75 hours)

The maximum number of registrations for this event has been reached.

Ronald Reagan International Trade Center
1300 Pennsylvania Avenue, NW
Washington, DC 20004
Click Here for Venue Website

Mitigation of Relevant Financial Relationships

MedStar Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education.

Individuals in a position to control the content of this CE activity, including faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible companies. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships listed below have been mitigated prior to the commencement of the activity.